95 related articles for article (PubMed ID: 30184235)
21. Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets.
McNicol A; Jackson EC
Biochem Pharmacol; 2003 Apr; 65(8):1243-50. PubMed ID: 12694865
[TBL] [Abstract][Full Text] [Related]
22. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of mitogen-activated protein kinase kinase blocks proliferation of neural progenitor cells.
Learish RD; Bruss MD; Haak-Frendscho M
Brain Res Dev Brain Res; 2000 Jul; 122(1):97-109. PubMed ID: 10915910
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
Dai Y; Yu C; Singh V; Tang L; Wang Z; McInistry R; Dent P; Grant S
Cancer Res; 2001 Jul; 61(13):5106-15. PubMed ID: 11431348
[TBL] [Abstract][Full Text] [Related]
25. Osteocalcin Induces Proliferation via Positive Activation of the PI3K/Akt, P38 MAPK Pathways and Promotes Differentiation Through Activation of the GPRC6A-ERK1/2 Pathway in C2C12 Myoblast Cells.
Liu S; Gao F; Wen L; Ouyang M; Wang Y; Wang Q; Luo L; Jian Z
Cell Physiol Biochem; 2017; 43(3):1100-1112. PubMed ID: 28977794
[TBL] [Abstract][Full Text] [Related]
26. Effects of U0126 and fibroblast growth factor on gene expression profile in Ciona intestinalis embryos as revealed by microarray analysis.
Sakabe E; Tanaka N; Shimozono N; Gojobori T; Fujiwara S
Dev Growth Differ; 2006 Aug; 48(6):391-400. PubMed ID: 16872452
[TBL] [Abstract][Full Text] [Related]
27. 1,4-Diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) enhances the cytotoxicity of combretastatin A4 independently of mitogen-activated protein kinase kinase.
Quan H; Liu H; Li C; Lou L
J Pharmacol Exp Ther; 2009 Jul; 330(1):326-33. PubMed ID: 19377096
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia.
Wang ZQ; Wu DC; Huang FP; Yang GY
Brain Res; 2004 Jan; 996(1):55-66. PubMed ID: 14670631
[TBL] [Abstract][Full Text] [Related]
29. Roles of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells.
Kimata M; Inagaki N; Kato T; Miura T; Serizawa I; Nagai H
Biochem Pharmacol; 2000 Aug; 60(4):589-94. PubMed ID: 10874134
[TBL] [Abstract][Full Text] [Related]
30. Potentiation of cadmium-induced cytotoxicity by sulfur amino acid deprivation through activation of extracellular signal-regulated kinase1/2 (ERK1/2) in conjunction with p38 kinase or c-jun N-terminal kinase (JNK). Complete inhibition of the potentiated toxicity by U0126 an ERK1/2 and p38 kinase inhibitor.
Son MH; Kang KW; Lee CH; Kim SG
Biochem Pharmacol; 2001 Nov; 62(10):1379-90. PubMed ID: 11709198
[TBL] [Abstract][Full Text] [Related]
31. Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways.
Kapur S; Baylink DJ; Lau KH
Bone; 2003 Mar; 32(3):241-51. PubMed ID: 12667551
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the phosphodiesterase 4 (PDE4) enzyme reverses memory deficits produced by infusion of the MEK inhibitor U0126 into the CA1 subregion of the rat hippocampus.
Zhang HT; Zhao Y; Huang Y; Dorairaj NR; Chandler LJ; O'Donnell JM
Neuropsychopharmacology; 2004 Aug; 29(8):1432-9. PubMed ID: 15114341
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells.
Wang X; Studzinski GP
Exp Cell Res; 2001 Aug; 268(2):294-300. PubMed ID: 11478855
[TBL] [Abstract][Full Text] [Related]
34. Effect of inhibitors of mitogen-activated protein kinase kinase on alpha(1B)-adrenoceptor phosphorylation.
Alcántara-Hernández R; Adolfo García-Sáinz J
Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):13-23. PubMed ID: 19302552
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the extracellular signal-regulated protein kinase (ERK) pathway in the induction of apoptosis by cadmium chloride in CCRF-CEM cells.
Iryo Y; Matsuoka M; Wispriyono B; Sugiura T; Igisu H
Biochem Pharmacol; 2000 Dec; 60(12):1875-82. PubMed ID: 11108803
[TBL] [Abstract][Full Text] [Related]
36. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
Jones NC; Fedorov YV; Rosenthal RS; Olwin BB
J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition.
Beloueche-Babari M; Jackson LE; Al-Saffar NM; Workman P; Leach MO; Ronen SM
Cancer Res; 2005 Apr; 65(8):3356-63. PubMed ID: 15833869
[TBL] [Abstract][Full Text] [Related]
38. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
39. Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen.
Somnier FE
J Neuroimmunol; 1994 Apr; 51(1):63-8. PubMed ID: 8157737
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy.
Papademetrio DL; Lompardía SL; Simunovich T; Costantino S; Mihalez CY; Cavaliere V; Álvarez É
Target Oncol; 2016 Apr; 11(2):183-95. PubMed ID: 26373299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
